N@N

MYGN, CETV, MOLX, ITMN, ENTG, RFMD, Expected to Trade Lower After Bearish Insider Trading

^{Published on 2011-06-13 06:20:32 - WOPRAI}
 

June 13, 2011 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring top insider trading patterns and these stocks are the most likely to trade Lower in the next 6 months. MYRIAD GENETICS INC (NASDAQ:MYGN), CENTRAL EUROPEAN MEDIA ENTERPRISES LTD (NASDAQ:CETV), MOLEX INCORPORATED (NASDAQ:MOLX), INTERMUNE, INC. (NASDAQ:ITMN), ENTEGRIS, INC. (NASDAQ:ENTG), RF MICRO DEVICES, INC. (NASDAQ:RFMD) are all expected to go Lower as Sell signals have been generated by top insider trading patterns. The most important data elements considered when performing insider analysis are: Insiders Track Record - An insiders track record is best summarized by the Insider Score which ranges from 1 (least predictive) to 100 (most predictive) based on prior trading performance. In addition, the actual returns following the insiders prior trades are included to determine the potential magnitude of future returns. Insiders Role - Trades by higher-level insiders are generally more predictive than trades by lower level insiders. Higher-level insiders to include Chairman (CB), Chief Executive Officer (CEO), President (P), Chief Financial Officer (CFO), and Vice Chairman (VC).

The chart below displays the stocks expected to go Lower along with the insider name, position, predictive insider score, 6 month expected return and number of trading decisions included in the score.

     Symbol     Company Name                        Insider Name                        Role        Shares         Insider Score     Avg 6 Month Return     # of Dec. 
     MYGN       MYRIAD GENETICS INC                 Evans, James S                      CFO         10,000         79                -14.9%                 7         
     CETV       CENTRAL EUROPEAN MEDIA ENTERPRISES LTD     Sarbu, Adrian                       CEO         50,000         76                -2.7%                  7         
     MOLX       MOLEX INCORPORATED                  Slark, Martin P                     CEO         20,233         76                -0.6%                  17        
     ITMN       INTERMUNE, INC.                     Simon, Howard Allan                 O           30,754         95                -34.8%                 7         
     ENTG       ENTEGRIS, INC.                      Graves, Gregory B                   CFO         33,320         76                -4.5%                  28        
     RFMD       RF MICRO DEVICES, INC.              Rudy, Suzanne B                     OT          23,304         81                -5.3%                  39        

MYRIAD GENETICS INC (NASDAQ:MYGN) - Myriad Genetics, Inc., a molecular diagnostic company, focuses on the development and marketing of novel predictive medicine, personalized medicine, and prognostic medicine products. The company markets BRACAnalys for the treatment of hereditary breast and ovarian cancer; COLARIS molecular for hereditary colorectal and uterine cancer; COLARIS AP for the treatment of hereditary colon cancer; and MELARIS to treat hereditary melanoma. It also offers TheraGuide 5-FU for chemotherapy toxicity to 5-FU; PREZEON that assess PTEN status for disease progression and drug response; OnDose, a personalized medicine product to measure chemotherapy exposure to 5-FU; Prolaris to treat prostate cancer; and Panexia for the treatment of pancreatic and related cancer. Myriad Genetics, Inc. was founded in 1991 and is headquartered in Salt Lake City, Utah.

CENTRAL EUROPEAN MEDIA ENTERPRISES LTD (NASDAQ:CETV) - Central European Media Enterprises Ltd. (CME) operates as a vertically integrated media company operating broadcast, content, and new media businesses in central and eastern European countries. CMEs television stations in Bulgaria comprise bTV, bTV Cinema, bTV Comedy, bTV Action, and Ring.bg; in Croatia include Nova TV, Doma, and Nova World; in the Czech Republic consist of TV Nova, Nova Cinema, Nova Sport, and MTV Czech; in Romania comprise PRO TV, PRO TV International, Acasa, PRO Cinema, PRO TV Chisinau, Sport.ro, and MTV Romania; in the Slovak Republic include TV Markza and Doma; and in Slovenia consist of POP TV, Kanal A, and POP Brio. The company was founded in 1994 and is based in Hamilton, Bermuda.

MOLEX INCORPORATED (NASDAQ:MOLX) - Molex Incorporated manufactures and sells electronic components worldwide. The company offers micro-miniature connectors, SIM card sockets, keypads, electromechanical subassemblies, and internal antennas and subsystems for telecommunications market; and power, optical, and signal connectors and cables for end-to-end data transfer, linking disk drives, controllers, servers, switches, and storage enclosures for data products market. It also designs and manufactures connectors for home and portable audio, digital still and video cameras, DVD players, and recorders, as well as devices that combine multiple functions in the consumer market, as well as devices that combine multiple functions. In addition, the company manufactures cables, backplanes, power connectors, and integrated products that are found in various products, such as electronic weighing stations, and industrial microscopes and vision systems; interface cards, software for industrial networks, and connectivity solutions; and compact robotic connectors and I/O connectors for servo motors, as well as a range of products for automotive market. Further, it provides connectors and custom integrated systems for diagnostic and therapeutic equipment used in hospitals, including x-ray, magnetic resonance imaging, and dialysis machines. Additionally, the company provides manufacturing services to integrate specific components into a customers product. It sells its products to original equipment manufacturers, contract manufacturers, and distributors. Molex Incorporated was founded in 1938 and is based in Lisle, Illinois.

INTERMUNE, INC. (NASDAQ:ITMN) - InterMune, Inc., a biotech company, focuses on developing and commercializing therapies in pulmonology and hepatology primarily in the United States and Europe. The company primarily offers Actimmune for the treatment of patients with severe, malignant osteopetrosis, and chronic granulomatous disease. Its pulmonology product portfolio includes lead product candidate, pirfenidone, a phase III product being developed for the treatment of patients with idiopathic pulmonary fibrosis; and a research program focused on small molecules for pulmonary diseases. The companys hepatology portfolio comprises the HCV protease inhibitor RG7227, a phase IIb chronic hepatitis C program and an early stage research program evaluating a new target in hepatology. It has license and collaboration agreements with Genentech, Inc.; Boehringer Ingelheim International GmbH; Connetics Corporation; and Novartis Corporation. The company was founded in 1998 and is headquartered in Brisbane, California.

ENTEGRIS, INC. (NASDAQ:ENTG) - Entegris, Inc. develops, manufactures, and supplies products and materials used in processing and manufacturing in the semiconductor and other high-technology industries worldwide. It operates in three segments: Contamination Control Solutions, Microenvironments, and Specialty Materials. The Contamination Control Solutions segment offers liquid filtration products, components and systems, and gas filtration products that purify, monitor, and deliver critical liquids and gases to the semiconductor manufacturing process. The Microenvironments segment provides wafer and reticle handling products, wafer shipping products, and data storage products, which preserve the integrity of wafers, reticles, and electronic components at various stages of transport, processing, and storage. The Specialty Materials segment offers poco graphite products and specialty coating products that provide low-temperature and plasma-enhanced chemical vapor deposition coatings of critical components of semiconductor manufacturing equipment used in various stages of the manufacturing process. The company sells its products primarily through direct sales force, and strategic and independent distributors to integrated circuit device manufacturers, original equipment manufacturers (OEM), gas and chemical manufacturing companies, and high-precision electronics manufacturers; and electrical discharge machining customers, glass container manufacturers, aerospace manufacturers, and biomedical implantation device manufacturers, as well as flat panel display OEMs, materials suppliers, and end users. Entegris, Inc. was founded in 1966 and is based in Billerica, Massachusetts.

RF MICRO DEVICES, INC. (NASDAQ:RFMD) - RF Micro Devices, Inc. designs and manufactures radio frequency components and compound semiconductors in the United States and internationally. The company provides integrated circuits, including gain blocks, LNAs, PAs, receivers, transmitters, transceivers, modulators, demodulators, attenuators, switches, frequency synthesizers, and voltage-controlled oscillators. It also offers multi-chip modules comprising PA modules, switch-filter modules, active antenna products, VCOs, phase-locked loops, coaxial resonator oscillators, active mixers, variable gain amplifiers, hybrid amplifiers, power doublers, and optical receivers. In addition, the company provides passive components, such as splitters, couplers, mixers, transformers, isolators, and circulators; and foundry services for gallium nitride wafer production. Its products enable worldwide mobility and provide connectivity and support advanced functionality in the cellular handset, wireless infrastructure, wireless local area network, cable television/broadband, and aerospace and defense markets. The company serves commercial, industrial, military, aerospace, and other markets in wireless and wired communications applications. RF Micro Devices, Inc. sells its products to original equipment manufacturers and original design manufacturers through a network of sales representative firms and distributors. The company was founded in 1991 and is headquartered in Greensboro, North Carolina.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

Insider Trading tracks all insider trades and selects those insider buys that predict higher moves and insider sales that predict lower moves.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net